Primary immune deficiency disorder
Information
- Disease name
- Primary immune deficiency disorder
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03037359 | Active, not recruiting | A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products | December 2016 | June 30, 2023 | |
| NCT03301168 | Active, not recruiting | Phase 1/Phase 2 | Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant | April 2014 | May 2034 |
| NCT03988426 | Completed | Phase 3 | Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases | March 7, 2017 | January 26, 2018 |
| NCT03618147 | Completed | Primary Immunodeficiency in Kuwait | July 16, 2018 | May 1, 2019 | |
| NCT01888484 | Completed | Phase 3 | Study of Octanorm Subcutaneous IG in Patients With PID | March 2014 | June 9, 2020 |
| NCT02327351 | Completed | Phase 2/Phase 3 | TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID | July 2012 | June 2018 |
| NCT02888535 | Completed | Intensive Care Unit and Secondary and Primary Immune Deficiency | January 2015 | December 2019 | |
| NCT03069079 | Completed | N/A | Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study | December 2016 | December 2019 |
| NCT03939533 | Completed | Phase 3 | Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases | October 17, 2019 | January 3, 2022 |
| NCT03211689 | Completed | N/A | The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease | June 27, 2017 | December 31, 2017 |
| NCT01458171 | Completed | Phase 3 | Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) | April 2011 | April 2012 |
| NCT01814800 | Completed | Phase 3 | Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD) | February 2014 | January 2015 |
| NCT01131858 | Completed | Phase 1/Phase 2 | Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency | March 2010 | June 2011 |
| NCT01859754 | Completed | Octagam 5% Versus Comparator Post Marketing Trial | May 21, 2013 | May 22, 2019 | |
| NCT03266640 | Recruiting | Phase 2 | Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) | November 1, 2018 | December 31, 2024 |
| NCT03266627 | Recruiting | Phase 2 | Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection | November 1, 2018 | December 31, 2024 |
| NCT03266653 | Recruiting | Phase 2 | EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection | July 7, 2020 | December 31, 2025 |
| NCT03414528 | Recruiting | Identification of New Inborn Errors of Immunity | August 15, 2015 | August 15, 2025 | |
| NCT03422614 | Recruiting | Pathophysiology of Inborn Immunodeficiencies | July 1, 2015 | July 1, 2025 | |
| NCT04197596 | Recruiting | Phase 1/Phase 2 | Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) | July 1, 2020 | June 30, 2025 |
| NCT04232085 | Recruiting | Phase 2 | Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide | February 12, 2020 | December 31, 2026 |
| NCT04354129 | Recruiting | Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency. | April 1, 2023 | June 2024 | |
| NCT01883921 | Terminated | Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI) | June 2013 | August 2019 | |
| NCT04354818 | Unknown status | Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) | May 11, 2020 | April 27, 2022 | |
| NCT03148028 | Unknown status | Immunological Characteristics of Patients With PID and IBD | May 15, 2017 | December 31, 2020 | |
| NCT03492710 | Withdrawn | Phase 3 | Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency | April 30, 2019 | April 30, 2019 |
- MedGen concept unique identifier (MedGen Concept name)
- C0398686
- MedGen unique identifier (MedGen Concept name)
- 585013